We speculate that the patient may be the initial case of Lynch syndrome (i.e., the proband) and that the occurrence of the tumor due to CIC-NUTM1 gene rearrangement may not be directly related, potentially operating in separate pathogenic pathways, with the former not yet manifesting clinically. This evidence concerns the gene NUTM1 and Lynch syndrome.